Stryde Research | Frisco, TX
Research site
Site insights
Top conditions
Top treatments
Erenumab
Vonoprazan
Parent organization
This site is a part of Stryde Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Contact this site
Chintan Desai
Verified by this site
Active trials
2 of 3 total trials
This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to \<12 years) and adolescents (12 to \<18 years)...
Enrolling
Migraine
Drug: Erenumab Dose 3
Drug: Erenumab Dose 1
This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to \<12 years) and adolescents (12 to \<18 years)...
Active, not recruiting
Migraine
Drug: Erenumab Dose 2
Drug: Erenumab Dose 3
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems